JOURNAL TOOLS |
Publishing options |
eTOC |
To subscribe |
Submit an article |
Recommend to your librarian |
ARTICLE TOOLS |
Publication history |
Reprints |
Permissions |
Cite this article as |
Share |
YOUR ACCOUNT
YOUR ORDERS
SHOPPING BASKET
Items: 0
Total amount: € 0,00
HOW TO ORDER
YOUR SUBSCRIPTIONS
YOUR ARTICLES
YOUR EBOOKS
COUPON
ACCESSIBILITY
CASE REPORT
Gazzetta Medica Italiana - Archivio per le Scienze Mediche 2019 September;178(9):715-20
DOI: 10.23736/S0393-3660.18.03919-0
Copyright © 2018 EDIZIONI MINERVA MEDICA
language: English
High doses of vasoactive drugs in treatment of refractory septic shock in elderly patient
Gordana CAVRIĆ 1 ✉, Ingrid PRKAČIN 1, Khaled NASSABAIN 2, Maja VUČKOVIĆ 1, Dubravka BARTOLEK HAMP 3, 4, Kristina NJERŠ 5
1 Department of Internal Medicine, Merkur University Hospital, Zagreb, Croatia; 2 Department of Gynecology and Obstetrics, Hospital of Lauter, Wissembourg, France; 3 Department of Anesthesiology, Resuscitation and Intensive Care, General Hospital of Dubrovnik, Dubrovnik, Croatia; 4 Medical School, J.J. Strossmayer University, Osijek, Croatia; 5 Department of Anesthesiology, Resuscitation and Intensive Care, Dr Josip Benčević Hospital, Slavonski Brod, Croatia
We have shown the case of an 87-year-old man with a refractory septic shock, who was treated in the medical intensive care unit (MICU) with high doses of 4 vasculactive drugs. During the first phase of treatment, the patient overcomes the shock situation, but on the 14th day, when the intensive treatment measures were abandoned, he died. A new deterioration may have occurred due to the prevailing effect of the “immunosuppressive phase of sepsis,” potentiated by weak immunity in the elderly persons and by the immunosuppressive effect of catecholamines.
KEY WORDS: Vasodilator agents; Vasoconstrictor agents; Shock, septic; Aged